Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neurocrine Biosciences (NBIX) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $25.8 million.

  • Neurocrine Biosciences' Interest & Investment Income rose 1466.67% to $25.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $90.3 million, marking a year-over-year decrease of 76.92%. This contributed to the annual value of $90.3 million for FY2025, which is 76.92% down from last year.
  • According to the latest figures from Q4 2025, Neurocrine Biosciences' Interest & Investment Income is $25.8 million, which was up 1466.67% from $22.2 million recorded in Q3 2025.
  • In the past 5 years, Neurocrine Biosciences' Interest & Investment Income registered a high of $25.8 million during Q4 2025, and its lowest value of $800000.0 during Q3 2021.
  • For the 4-year period, Neurocrine Biosciences' Interest & Investment Income averaged around $15.9 million, with its median value being $20.6 million (2025).
  • Per our database at Business Quant, Neurocrine Biosciences' Interest & Investment Income plummeted by 7500.0% in 2021 and then soared by 12755.1% in 2024.
  • Neurocrine Biosciences' Interest & Investment Income (Quarter) stood at $800000.0 in 2021, then soared by 2262.5% to $18.9 million in 2023, then rose by 19.05% to $22.5 million in 2024, then grew by 14.67% to $25.8 million in 2025.
  • Its last three reported values are $25.8 million in Q4 2025, $22.2 million for Q3 2025, and $20.6 million during Q2 2025.